Segments - Legionella Testing Products Market By Product (Bottles, Kits, Other Products), By Material (Plastic, Glass), By Distribution Channel (Direct Sale and Indirect Sale), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2030
The global legionella testing products market size was estimated at USD 289.8 Mn in 2021 and is anticipated to reach USD 656.0 Mn by 2030, expanding at a CAGR of 9.8% during the forecast period.
Legionella is a type of bacteria that causes a serious respiratory illness known as legionnaires' disease, a severe form of pneumonia, and pontiac fever. Legionella testing bottles and kits are used to detect the presence of legionella bacteria in water samples. According to the Centers for Disease Control and Prevention (CDC), about 8,000 to 18,000 people are hospitalized with Legionnaires disease each year in the US.
Different types of legionella testing bottles and kits are available in the market. Legionella testing bottles are used to collect a water sample from the system being tested. The water sample is sent to a laboratory for analysis. The laboratory uses various methods, such as polymerase chain reaction (PCR) tests, to detect the presence of legionella bacteria in the sample.
The regulatory farmwork for legionella testing varies by region, which is considered to boost the demand for legionella testing products. Government and regulatory bodies around the globe have mandated strict regulations for legionella testing in healthcare facilities, hospitality industry, and public buildings. These factors are anticipated to fuel the market during the forecast period. Changes in regulations related to water safety and healthcare are anticipated to significantly impact the legionella testing products market.
The outbreak of Coronavirus disease in 2019 (COVID-19) restrained the global economy, created global interdependence, and challenged governments of various nations. COVID-19 is a public health emergency that affected almost every industry. The long-term effects of the pandemic are expected to affect the growth of various industries during the forecast period, especially across Eastern Europe, European Union, the US, and Eastern & Central Asia.
The COVID-19 pandemic positively impacted the Legionella testing products market, due to imposition of lockdown across globe, resulted in empty buildings and reduction in water usage. The unused water and empty buildings resulted in growth of Legionella pathogen in the water. The rise in the growth of Legionella species, increased its usage in environmental water testing in the pandemic.
Rising Demand for Rapid Diagnostic Methods
Molecular diagnostics, such as the polymerase chain reaction (PCR) approach, have emerged as one of the most often used tests for determining the virulence of legionella among several testing options. PCR testing is carried out at labs and medical facilities. PCR testing is one of the most reliable ways to find legionella, due to its good specificity and high sensitivity. Increasing demand for rapid diagnostic methods is anticipated to propel the legionella testing products market during the forecast period.
Increasing Prevalence of Pneumonia and Legionella-related Illnesses
Legionella pneumonia is a relatively uncommon cause of community-acquired pneumonia. Growing awareness pertaining to the risk of legionella-borne diseases from water bodies is a key factor that is driving the legionella testing product market. Increasing incidence of hospital-acquired legionella infection and rising frequency of testing in these facilities due to stringent regulations are expected to boost the demand for legionella testing products in the near future. Rising incidence of pneumonia and legionella-related illnesses is expected to fuel the legionella testing product market during the forecast period.
Legionnaire’s disease is underdiagnosed in many countries, due to lack of awareness, guidelines, and diagnostic facilities, which is considered to hinder the market growth. Governments of developed countries have formed stringent regulations for the diagnosis of associated diseases and regular testing of any source of infection. Awareness about the bacteria and the diseases associated with it is low in the emerging regions.
Sporadic diseases such as legionnaires disease generally are unnoticed, due to the high prevalence of other diseases in underdeveloped countries. Thus, limited awareness about the diseases, lack of sufficient diagnostic infrastructure, and slow adoption of advanced diagnostic tools such as real time PCR are some factors that are projected to hamper the legionella testing products market growth during the forecast period.
The outbreak of legionellosis results in increased risk of morbidity and mortality among exposed people. The World Health Organization (WHO) provides information and guidance on assessment of legionella risk and its proper management. Governments of several countries have enacted regulations to manage legionella in various types of water systems.
For instance, the European Union (EU) formed the European Working Group for Legionella Infections (EWGLI) to control the prevalence of legionnaire’s disease. Thus, stringent monitoring of water reservoirs and launch of rapid testing methods for onsite water testing are anticipated to offer opportunities for the market growth.
The report on the Global Legionella Testing Products Market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Legionella Testing Products Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
Base Year |
2021 |
Historic Data |
2015–2020 |
Forecast Period |
2022–2030 |
Segmentation |
By Product (Bottles, Kits, Other Products), By Material (Plastic, Glass), By Distribution Channel (Direct Sale and Indirect Sale) |
Regional Scope |
Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered |
Abbott, Bio-Rad Laboratories, Inc., Biomeriux SA, IDEXX, Asahi Kasei Corporation, Thermo Fischer Scientific Inc, Hardy Diagnostics, Accepta Water Treatment, Merck KGaA, and ALBAGAIA (Hydrosense Ltd). |
Based on product, the legionella testing products market is segmented into bottles, kits, and other products. The bottle segment is projected to expand at a significant CAGR during the forecast period. The strict regulations and guidelines for legionella testing & control and increasing legionella testing are expected to drive the bottles segment in near future.
Based on the material, the global legionella testing products market is bifurcated into plastic and glass. The plastic segment is projected to expand at a considerable CAGR during the forecast period, owing to the rising use of plastic materials in legionella testing products for their lightweight, cost-effectiveness, and ease-in-transport.
Based on the Distribution Channel, the market is bifurcated into direct sale and indirect sale. The direct sale segment is projected to hold significant market share during the forecast period. Manufacturers of legionella testing products differentiate themselves by offering high-quality and reliable products. Building a reputation for quality and reliability is likely to drive direct sales in the coming years.
Based on regions, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the North America is projected to expand at a significant CAGR during the forecast period. Stringent regulations and guidelines enacted in the region that required testing for legionella bacteria in certain facilities, such as hospitals and large buildings with complex water systems, are projected to boost the market growth in the coming years.
The market in Europe is expected to register a remarkable CAGR during the forecast period, due to the stringent water testing regulations and high diagnosis rates for legionnaire disease in the region.
Manufacturers operating in the Global Legionella Testing Products Market includes Abbott, Bio-Rad Laboratories, Inc., Biomeriux SA, IDEXX, Asahi Kasei Corporation, Thermo Fischer Scientific Inc, Hardy Diagnostics, Accepta Water Treatment, Merck KGaA, and ALBAGAIA (Hydrosense Ltd). Market Players are pursuing key strategies such as acquisitions, collaborations, and geographic expansion where a potential opportunity arises for the Global Legionella Testing Products Market.
Additional company profiles can be provided on request. For a discussion related to the above findings, click Speak to Analyst
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
Rising demand for rapid diagnostic methods and increasing prevalence of pneumonia and legionella-related illnesses are the factors expected to drive the market growth during the forecast period.
The Global Legionella Testing Products Market is likely to register a CAGR of 9.8% during the forecast period, with a projected valuation of USD 656.0 million by the end of 2030.
Factors such as economic growth and development, regulatory framework, and health awareness & environmental factors are analyzed in the final report.
Major manufacturers include Abbott, Bio-Rad Laboratories, Inc., Biomeriux SA, IDEXX, Asahi Kasei Corporation, and Thermo Fischer Scientific Inc.
The COVID-19 pandemic positively impacted the Legionella testing products market, due to imposition of lockdown across globe, resulted in empty buildings and reduction in water usage.
In addition to market size (in US$ Million), Company Market Share (in % for the base year 2021), macroeconomic factors, and supply chain analysis.
The base year considered for the Global Legionella Testing Products Market report is 2021. The complete analysis period is 2015 to 2030 and the forecast is provided from 2022 to 2030.